Go Pro

Humana (HUM) Stock Price, News & Analysis

Humana logo
$366.66 +1.25 (+0.34%)
Closing price 04:00 PM Eastern
Extended Trading
$367.53 +0.87 (+0.24%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Humana Stock (NYSE:HUM)

Advanced

Key Stats

Today's Range
$357.38
$376.45
50-Day Range
$302.69
$409.92
52-Week Range
$163.11
$428.88
Volume
2.37 million shs
Average Volume
1.82 million shs
Market Capitalization
$44.02 billion
P/E Ratio
39.21
Dividend Yield
0.97%
Price Target
$383.00
Consensus Rating
Hold

Company Overview

Humana Inc. (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination. The company works through networks of clinicians, hospitals and pharmacies and has developed programs to integrate medical and pharmacy benefits, promote value-based arrangements with providers, and deliver services in community and home settings. Humana also operates initiatives aimed at addressing social determinants of health and improving access to health services for its members.

Humana’s operations are focused on the U.S. market and include product offerings for Medicare, Medicaid-managed care, and employer-sponsored plans where applicable. The company has been shifting toward integrated, value-based care models and partnerships with provider organizations to enhance care continuity and control costs. It also invests in technology and analytics to support population health management and member engagement.

Humana is publicly traded on the New York Stock Exchange under the ticker HUM. Bruce D. Broussard serves as president and chief executive officer, leading the company’s strategic focus on senior care, value-based provider relationships and expanding services that support members beyond traditional insurance coverage.

AI Generated. May Contain Errors.

Humana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

HUM MarketRank™: 

Humana scored higher than 80% of companies evaluated by MarketBeat, and ranked 125th out of 832 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Humana has received a consensus rating of Hold. The company's average rating score is 2.47, and is based on 1 strong buy rating, 14 buy ratings, 13 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Humana is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Humana has been the subject of 27 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Humana's stock forecast and price target.
  • Earnings Growth

    Earnings for Humana are expected to grow by 64.06% in the coming year, from $9.46 to $15.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Humana is 39.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.99.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Humana is 39.21, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.62.

  • Price to Earnings Growth Ratio

    Humana has a PEG Ratio of 2.12. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Humana has a P/B Ratio of 2.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.55% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 3.23, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently decreased by 1.75%, indicating that investor sentiment is improving.
  • Dividend Yield

    Humana has a dividend yield of 0.91%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Humana does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Humana is 33.49%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Humana will have a dividend payout ratio of 22.81% next year. This indicates that Humana will be able to sustain or increase its dividend.

  • Read more about Humana's dividend.
  • News Sentiment

    Humana has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 47 news articles for Humana this week, compared to 10 articles on an average week.
  • Search Interest

    15 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Humana insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.20% of the stock of Humana is held by insiders.

  • Percentage Held by Institutions

    92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Humana's insider trading history.
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HUM Stock News Headlines

UnitedHealth Group name displayed on a glass panel surrounded by abstract molecular and DNA-like imagery.
UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal (HUM)
UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.
BREAKING: Bill Gates Says It’s “Worth 10 Microsofts”
Nvidia is up 203% this year. Microsoft, Amazon, Apple, and Alphabet have each surged between 36% and 62%. But one analyst believes the biggest AI winner hasn't been discovered yet. He calls it the 'AI Wonder Stock' - a company with a market cap less than 1/1,000th of Microsoft's, still early-stage while the AI wave builds momentum.tc pixel
Humana drops despite Q2 beat on unchanged outlook
Humana earnings rise as Medicare overhaul takes shape
See More Headlines

HUM Stock Analysis - Frequently Asked Questions

Humana's stock was trading at $256.35 at the beginning of the year. Since then, HUM shares have increased by 43.0% and is now trading at $366.66.

Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, July, 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts' consensus estimates of $7.26 by $0.35. The company's revenue for the quarter was up 26.2% on a year-over-year basis.
Read the conference call transcript
.

Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others.

Humana's top institutional investors include Czech National Bank (0.03%), Mirae Asset Global Investments Co. Ltd. (0.02%), PensionDanmark Pensionsforsikringsaktieselskab (0.02%) and Sumitomo Mitsui DS Asset Management Company Ltd (0.01%). Insiders that own company stock include Sanjay K Shetty, Timothy S Huval and Jorge S Mesquita.
View institutional ownership trends
.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 7/31 Dividend
6/26/2026
Ex-Dividend for 7/31 Dividend
6/26/2026
Last Earnings
7/29/2026
Today
7/30/2026
Dividend Payable
7/31/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:HUM
CIK
49071
Employees
67,060
Year Founded
1961

Price Target and Rating

High Price Target
$513.00
Low Price Target
$195.00
Potential Upside/Downside
+4.5%
Consensus Rating
Hold
Rating Score (0-4)
2.47
Research Coverage
30 Analysts

Profitability

EPS (Trailing Twelve Months)
$10.57
Trailing P/E Ratio
39.21
Forward P/E Ratio
38.76
P/E Growth
2.12
Net Income
$1.19 billion
Net Margins
0.82%
Pretax Margin
1.06%
Return on Equity
10.45%
Return on Assets
3.75%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
1.77
Quick Ratio
1.77

Sales & Book Value

Annual Sales
$137.20 billion
Price / Sales
0.32
Cash Flow
$22.70 per share
Price / Cash Flow
16.15
Book Value
$147.47 per share
Price / Book
2.49

Miscellaneous

Outstanding Shares
120,062,000
Free Float
119,822,000
Market Cap
$44.02 billion
Optionable
Optionable
Beta
0.71

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NYSE:HUM) was last updated on 7/30/2026 by MarketBeat.com Staff.
From Our Partners